Developer of drugs for the treatment of cancer and inflammatory diseases. The company uses software and AI-enhanced medicinal chemistry to develop novel drug candidates in the areas of oncology, inflammation, and pandemics response. Founded in 2020, headquartered in Paris, France. The company has raised $24.6M in funding at the seed stage. The team comprises 60 (Jun 30, 2026) employees. Backed by investors including XAnge, Quantonation, Omnes Capital, EIT Health. The company operates in the Life Sciences Platforms and Tools sector with additional focus on Oncology and Quantum Computing. Its business model centers on Simulation. Founded in 2020, headquartered in Paris, France. The company has raised $24.6M at the Seed stage. Backed by investors including XAnge, Quantonation, Omnes Capital, EIT Health, EIC Fund.
Qubit Pharmaceuticals
SeedDeveloper of drugs for the treatment of cancer and inflammatory diseases. The company uses software and AI-enhanced medicinal chemistry to develop novel drug candidates in the areas of oncology, inflammation, and pandemics response. Founded in 2020, headquartered in Paris, France. The company has raised $24.6M in funding at the seed stage. The team comprises 60 (Jun 30, 2026) employees. Backed by investors including…
About
Business model
Quantum Computing > Quantum Software > Development Platforms > Simulation,
Oncology > Drugs > Diversified,
Life Sciences Platforms and Tools > Research Services > Diversified
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.
Similar startups
Raising like Qubit Pharmaceuticals?
Analyze your pitch deck before your next raise.
Analyze My Deck →